Safety and Efficacy Evaluation of 4-month Regimen of OPC-167832, Delamanid and Bedaquiline in Participants With Drug-Susceptible Pulmonary TB
Clinical trial NCT05221502 · COMPLETED
Trial details
- NCT number
- NCT05221502
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-12
- Primary completion
- 2024-04-08
- Enrollment
- 122
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.